SMi Source Lesson Cardiovascular: Acute Coronary Syndrome

  • SMi Source lesson Cardiovascular: Acute Coronary Syndrome has the following microlearning topics

  • 1. Learning Objectives

    2. Introduction: Acute Coronary Syndrome

    3. Inflammation and Atherosclerosis: ACS

    4. Inflammation and Atherosclerosis: Atherogenesis

    5. Inflammation and Atherosclerosis Inflammation, Plaque Rupture, and Thrombosis

    6. Risk Factors and Atherosclerosis

    7. Risk Factors on the Rise

    8. Genetic Predisposition

    9. Pathophysiology of Atherothrombosis: Overview

    10. Atherogenesis

    11. Atherogenesis: Overview

    12. Atherogenesis: Lesion

    13. Plaque Rupture

    14. Thrombus Formation

    15. Acute Coronary Syndrome (ACS): Overview

    16. UA/NSTEMI

    17. Presentations of UA/NSTEMI

    18. STEMI

    19. Pathogenesis of ACS

    20. Prevalence and Incidence: CVD Statistics

    21. Recognition of Symptoms by Patient

    22. Diagnosis by Clinician: Management of Patients

    23. Diagnosis by Clinician: UA/NSTEMI

    24. Diagnosis by Clinician: Treatment of UA/NSTEMI

    25. Drug Therapy in ACS: Overview

    26. Drug Therapy in ACS: ACC/AHA Guidelines

    27. UA/NSTEMI: Anti-Ischemic Therapy

    28. Nitrates

    29. Beta Adrenergic Blockers

    30. Calcium Channel Blockers

    31. Inhibitors of Renin-Angiotensin System

    32. UA/NSTEMI: Analgesic Therapy: Morphine

    33. UA/NSTEMI: Antiplatelet Therapy

    34. Thienopyridines: Adenosine Diphosphate (ADP) Receptor (P2Y12) Antagonists

    35. Thienopyridines Approved for Antiplatelet Therapy

    36. GP IIb/IIIa Antagonists

    37. Approved GP IIb/IIIa Antagonists

    38. UA/NSTEMI: Anticoagulants

    39. Unfractionated Heparin (UFH)

    40. Low-Molecular-Weight Heparins (LMWHs)

    41. Direct Thrombin Inhibitors

    42. Factor Xa Inhibitors

    43. Long-Term Anticoagulation (Warfarin/Coumarin)

    44. STEMI: Analgesia

    45. STEMI: Anti-Ischemic Therapy Beta Blockers

    46. STEMI: Reperfusion

    47. Facilitated PCI

    48. Challenges

    49. Classification of Bleeding

    50. Need for Standardization of Bleeding Definition

    51. Incidence of Bleeding

    52. Bleeding Risk

    53. Clinical Consequences of Bleeding

    54. Independent Predictors of Mortality

    55. Transfusion Risks

    56. Minimizing Bleeding